REN-001 (Renovacor)

N/A

Report date: 2024/10/23 11:27:59

Base Information

Drug NameREN-001 (Renovacor)
Drug Alias NameREN-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBAG3 gene transference
TargetsBAG family molecular chaperone regulator 3
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRenovacor Inc
China Registration ClassN/A

Develop Information

Active CompaniesRenovacor Inc
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A